Collins Helen Louise

Kura Oncology, Inc. · Director

Collins Helen Louise is listed in public filings as director. This Collins Helen Louise insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Kura Oncology, Inc. (KURA), Enliven Therapeutics, Inc. (ELVN), and IO Biotech, Inc. (IOBT). Investors use Collins Helen Louise's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Kura Oncology, Inc.KURA	$307k35k shares	Grant / ExerciseJun 4, 2026	$306.9K35k shares	$8.77	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Enliven Therapeutics, Inc.ELVN	$1.0M26.5k shares	SellMay 18, 2026	$137.4K3.5k shares	$39.53	--
Enliven Therapeutics, Inc.ELVN	$1.0M25.2k shares	SellMay 18, 2026	$52.4K1.3k shares	$40.25	--
Enliven Therapeutics, Inc.ELVN	$74k30k shares	Grant / ExerciseMay 18, 2026	$12.4K5k shares	$2.48	--
Enliven Therapeutics, Inc.ELVN	$1.0M25k shares	SellMay 18, 2026	$9.2K223 shares	$41.21	--
Enliven Therapeutics, Inc.ELVN	$1.2M25k shares	SellApr 17, 2026	$117.3K2.4k shares	$48.06	--
Enliven Therapeutics, Inc.ELVN	$1.3M27.4k shares	SellApr 17, 2026	$114.6K2.4k shares	$47.39	--
Enliven Therapeutics, Inc.ELVN	$74k30k shares	Grant / ExerciseApr 17, 2026	$12.4K5k shares	$2.48	--
Enliven Therapeutics, Inc.ELVN	$1.4M29.9k shares	SellApr 17, 2026	$6.4K140 shares	$45.81	--
Enliven Therapeutics, Inc.ELVN	$878k25k shares	SellMar 25, 2026	$1.4M40k shares	$35.10	--
Enliven Therapeutics, Inc.ELVN	$161k65k shares	Grant / ExerciseMar 25, 2026	$99.2K40k shares	$2.48	--
Enliven Therapeutics, Inc.ELVN	$694k25k shares	SellMar 17, 2026	$138.8K5k shares	$27.76	--
Enliven Therapeutics, Inc.ELVN	$74k30k shares	Grant / ExerciseMar 17, 2026	$12.4K5k shares	$2.48	--
Enliven Therapeutics, Inc.ELVN	$755k25k shares	SellMar 10, 2026	$305.8K10.1k shares	$30.19	--
Enliven Therapeutics, Inc.ELVN	$87k35.1k shares	Grant / ExerciseMar 10, 2026	$25.1K10.1k shares	$2.48	--
Enliven Therapeutics, Inc.ELVN	$751k25k shares	SellMar 9, 2026	$896.8K29.9k shares	$30.02	--
Enliven Therapeutics, Inc.ELVN	$136k54.9k shares	Grant / ExerciseMar 9, 2026	$74.1K29.9k shares	$2.48	--
Enliven Therapeutics, Inc.ELVN	$654k25k shares	SellFeb 17, 2026	$1.2M45k shares	$26.17	--
Enliven Therapeutics, Inc.ELVN	$174k70k shares	Grant / ExerciseFeb 17, 2026	$111.6K45k shares	$2.48	--
Enliven Therapeutics, Inc.ELVN	$4.1M150k shares	Grant / ExerciseFeb 12, 2026	$4.1M150k shares	$27.16	--
Enliven Therapeutics, Inc.ELVN	--25k shares	Grant / ExerciseFeb 12, 2026	Disclosure amount unavailable25k shares	--	--
Kura Oncology, Inc.KURA	$187k28.5k shares	Grant / ExerciseJun 5, 2025	$187.2K28.5k shares	$6.57	--
IO Biotech, Inc.IOBT	$53k35.1k shares	Grant / ExerciseJun 5, 2025	$52.7K35.1k shares	$1.50	--
Enliven Therapeutics, Inc.ELVN	$3.8M171k shares	Grant / ExerciseFeb 6, 2025	$3.8M171k shares	$22.47	--
Enliven Therapeutics, Inc.ELVN	$2.0k816 shares	Grant / ExerciseOct 18, 2024	$2.0K816 shares	$2.48	--
Enliven Therapeutics, Inc.ELVN	$0816 shares	SellOct 18, 2024	$24.5K816 shares	$30.00	--